142 related articles for article (PubMed ID: 19509202)
41. Apolipoprotein E genotyping for Alzheimer's disease: ethical concerns and implications for clinical practice.
Abyad A; al Imad R
J Med Liban; 1999; 47(5):291-4. PubMed ID: 10887530
[No Abstract] [Full Text] [Related]
42. A philosophical critique of decision analysis as a tool in genetic testing.
Kaplan JM
Genet Test; 1999; 3(1):85-91. PubMed ID: 10464581
[TBL] [Abstract][Full Text] [Related]
43. The application of medical decision analysis to genetic testing: an introduction.
McConnell LM; Goldstein MK
Genet Test; 1999; 3(1):65-70. PubMed ID: 10464579
[TBL] [Abstract][Full Text] [Related]
44. Genetic testing must recognize impact of bad news on recipient.
Kosik KS; Lopera F
Nature; 2008 Jul; 454(7201):158-9. PubMed ID: 18615057
[No Abstract] [Full Text] [Related]
45. The effect of APOE genotype on clinical phenotype in Alzheimer disease.
Borroni B; Di Luca M; Padovani A
Neurology; 2007 Feb; 68(8):624; author reply 624. PubMed ID: 17310043
[No Abstract] [Full Text] [Related]
46. [Genetics of Alzheimer's disease].
Lambert JC
Rev Prat; 2011 Sep; 61(7):922-3. PubMed ID: 22039726
[No Abstract] [Full Text] [Related]
47. Predictive testing and Alzheimer disease.
Heger NE
Clin Chem; 2014 Dec; 60(12):1585-6. PubMed ID: 25580504
[No Abstract] [Full Text] [Related]
48. Decision analysis and Alzheimer disease: three case studies.
Holtzman S; Ozanne E; Carone B; Goldstein MK; Steinke G; Timbs J
Genet Test; 1999; 3(1):71-83. PubMed ID: 10464580
[TBL] [Abstract][Full Text] [Related]
49. Genetics, ethics, and Alzheimer disease.
Post SG
J Am Geriatr Soc; 1994 Jul; 42(7):782-6. PubMed ID: 8014357
[TBL] [Abstract][Full Text] [Related]
50. Systems Genetics of Alzheimer's Disease: From GWAS to Disease Pathways.
Li K
Curr Alzheimer Res; 2019; 16(13):1161-1162. PubMed ID: 31960790
[No Abstract] [Full Text] [Related]
51. Commentary on Spriggs: genetically selected baby free of inherited predisposition to early onset Alzheimer's disease.
Delatycki MB
J Med Ethics; 2003 Apr; 29(2):120. PubMed ID: 12672897
[No Abstract] [Full Text] [Related]
52. Perspectives in genetic prediction of Alzheimer's disease.
Šerý O; Povová J; Balcar VJ
Neuro Endocrinol Lett; 2014; 35(5):359-66. PubMed ID: 25275266
[TBL] [Abstract][Full Text] [Related]
53. Alzheimer's disease: epidemiology, genetics, and beyond.
Wang XP; Ding HL
Neurosci Bull; 2008 Apr; 24(2):105-9. PubMed ID: 18369390
[TBL] [Abstract][Full Text] [Related]
54. Alzheimer disease: 'generation next' in Alzheimer disease genetic studies.
Apostolova LG
Nat Rev Neurol; 2013 Aug; 9(8):422-3. PubMed ID: 23857046
[TBL] [Abstract][Full Text] [Related]
55. Accounting for individual differences in risk of Alzheimer disease.
Grant W
PLoS Med; 2005 Mar; 2(3):e82; author reply e86. PubMed ID: 15783264
[No Abstract] [Full Text] [Related]
56. Workshop report: genetic testing programs for familial Alzheimer's disease.
Meschino W; Lennox A
Alzheimer Dis Assoc Disord; 1994; 8(2):68-70. PubMed ID: 8060608
[No Abstract] [Full Text] [Related]
57. Susceptibility genes and the question of embodied identity.
Lock M; Freeman J; Chilibeck G; Beveridge B; Padolsky M
Med Anthropol Q; 2007 Sep; 21(3):256-76. PubMed ID: 17937249
[TBL] [Abstract][Full Text] [Related]
58. Informed consent for genetic research involving pleiotropic genes: an empirical study of ApoE research.
Cooper ZN; Nelson RM; Ross LF
IRB; 2006; 28(5):1-11. PubMed ID: 17152129
[No Abstract] [Full Text] [Related]
59. [Genetics of Alzheimer's disease].
Hiltunen M; Helisalmi S; Kivipelto M; Soininen H
Duodecim; 2004; 120(20):2425-31. PubMed ID: 15641511
[No Abstract] [Full Text] [Related]
60. Lack of association between Interleukin-18 gene promoter polymorphisms and onset of Alzheimer's disease.
Segat L; Milanese M; Arosio B; Vergani C; Crovella S
Neurobiol Aging; 2010 Jan; 31(1):162-4. PubMed ID: 18433937
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
